AAAAAA

   
Results: 1-17 |
Results: 17
TOTAL THYROIDECTOMY DOES NOT ENHANCE DISEASE-CONTROL OR SURVIVAL EVENIN HIGH-RISK PATIENTS WITH DIFFERENTIATED THYROID-CANCER
Authors: WANEBO H COBURN M TEATES D COLE B
Citation: H. Wanebo et al., TOTAL THYROIDECTOMY DOES NOT ENHANCE DISEASE-CONTROL OR SURVIVAL EVENIN HIGH-RISK PATIENTS WITH DIFFERENTIATED THYROID-CANCER, Annals of surgery, 227(6), 1998, pp. 912-918
TAXOL PRETREATMENT OF TUMOR TARGETS AMPLIFIES NATURAL-KILLER-CELL MEDIATED LYSIS
Authors: MEHTA S BLACKINTON D MANFREDI M RAJARATNAM D KOUTTAB N WANEBO H
Citation: S. Mehta et al., TAXOL PRETREATMENT OF TUMOR TARGETS AMPLIFIES NATURAL-KILLER-CELL MEDIATED LYSIS, Leukemia & lymphoma, 26(1-2), 1997, pp. 67-76
TAXOL AND CERAMIDE ACT SYNERGISTICALLY IN THE GROWTH-INHIBITION OF JURKAT, A LEUKEMIC T-CELL LINE
Authors: MYRICK D BLACKINTON D KLOSTERGAARD J WANEBO H MEHTA S
Citation: D. Myrick et al., TAXOL AND CERAMIDE ACT SYNERGISTICALLY IN THE GROWTH-INHIBITION OF JURKAT, A LEUKEMIC T-CELL LINE, The FASEB journal, 11(3), 1997, pp. 3157-3157
CONCURRENT PACLITAXEL, CARBOPLATIN, AND RADIOTHERAPY IN ADVANCED HEADAND NECK CANCERS - A PHASE-II STUDY - PRELIMINARY-RESULTS
Authors: CHOUGULE P WANEBO H AKERLEY W MCRAE R NIGRI P LEONE L SAFRAN H READY N KONESS RJ RADIEKEANE K COLE B
Citation: P. Chougule et al., CONCURRENT PACLITAXEL, CARBOPLATIN, AND RADIOTHERAPY IN ADVANCED HEADAND NECK CANCERS - A PHASE-II STUDY - PRELIMINARY-RESULTS, Seminars in oncology, 24(6), 1997, pp. 57-61
GASTRIC-CARCINOMA - DOES LYMPH-NODE DISSECTION ALTER SURVIVAL
Authors: WANEBO H KENNEDY BJ WINCHESTER DP FREMGEN A STEWART AK
Citation: H. Wanebo et al., GASTRIC-CARCINOMA - DOES LYMPH-NODE DISSECTION ALTER SURVIVAL, Journal of the American College of Surgeons, 183(6), 1996, pp. 616-624
PHASE-II STUDY OF 5-FLUORURACIL LEUCOVORIN AND AZIDOTHYMIDINE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: CLARK J SIKOV W CUMMINGS F BROWN M AKERLEY W WANEBO H WEITBERG A KENNEDY T COLE B BIGLEY J BEITZ J DARNOWSKI J
Citation: J. Clark et al., PHASE-II STUDY OF 5-FLUORURACIL LEUCOVORIN AND AZIDOTHYMIDINE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Journal of cancer research and clinical oncology, 122(9), 1996, pp. 554-558
INTERLEUKIN-6 PRODUCTION BY RAT HEPATOCELLULAR-CARCINOMA CELLS IS ASSOCIATED WITH METASTATIC POTENTIAL BUT NOT WITH TUMORIGENICITY - DISCUSSION
Authors: CADY B",REICHNER,"WANEBO H
Citation: H. Cady B",reichner,"wanebo, INTERLEUKIN-6 PRODUCTION BY RAT HEPATOCELLULAR-CARCINOMA CELLS IS ASSOCIATED WITH METASTATIC POTENTIAL BUT NOT WITH TUMORIGENICITY - DISCUSSION, Archives of surgery, 131(4), 1996, pp. 364-365
MULTIMODALITY TREATMENT OF HEPATOCELLULAR-CARCINOMA IN A HEPATOBILIARY SPECIALTY CENTER - DISCUSSION
Authors: WANEBO H
Citation: H. Wanebo, MULTIMODALITY TREATMENT OF HEPATOCELLULAR-CARCINOMA IN A HEPATOBILIARY SPECIALTY CENTER - DISCUSSION, Archives of surgery, 131(3), 1996, pp. 298-298
TIME-VARYING MAGNETIC-FIELD (MF) EFFECTS ON NORMAL HUMAN T-CELLS
Authors: MEHTA S BERG M CERRATO J CHERLIN D WANEBO H POLK C
Citation: S. Mehta et al., TIME-VARYING MAGNETIC-FIELD (MF) EFFECTS ON NORMAL HUMAN T-CELLS, The FASEB journal, 9(3), 1995, pp. 426-426
CONCURRENT CISPLATINUM AND RADIATION FOR ADVANCED HEAD AND NECK-CANCER - RESPONSE
Authors: GLICKMAN AS CLARK J COACHMAN N WANEBO H KONESS J DOOLITTLE C DEROSA E SLOTMAN G POSNER M
Citation: As. Glickman et al., CONCURRENT CISPLATINUM AND RADIATION FOR ADVANCED HEAD AND NECK-CANCER - RESPONSE, International journal of radiation oncology, biology, physics, 31(3), 1995, pp. 681-681
FURTHER CHARACTERIZATION OF A CLINICALLY RELEVANT MODEL OF MELANOMA METASTASIS AND AN EFFECTIVE VACCINE
Authors: SHRAYER D BOGAARS H HEARING VJ MAIZEL A WANEBO H
Citation: D. Shrayer et al., FURTHER CHARACTERIZATION OF A CLINICALLY RELEVANT MODEL OF MELANOMA METASTASIS AND AN EFFECTIVE VACCINE, Cancer immunology and immunotherapy, 40(5), 1995, pp. 277-282
SERUM-DERIVED IMMUNOSUPPRESSIVE FACTOR(S) FROM PATIENTS WITH HEAD ANDNECK-CANCER
Authors: AVRADOPOULOS D BLACKINTON D MEHTA S WANEBO H
Citation: D. Avradopoulos et al., SERUM-DERIVED IMMUNOSUPPRESSIVE FACTOR(S) FROM PATIENTS WITH HEAD ANDNECK-CANCER, The FASEB journal, 8(5), 1994, pp. 10000751-10000751
INHIBITION OF NEOPLASTIC B-CELL GROWTH BY PLASMA-DERIVED HUMAN GLOBULIN FRACTIONS (NHG)
Authors: BLACKINTON D MANFREDI M CHAN O GREEN S MEHTA S WANEBO H
Citation: D. Blackinton et al., INHIBITION OF NEOPLASTIC B-CELL GROWTH BY PLASMA-DERIVED HUMAN GLOBULIN FRACTIONS (NHG), The FASEB journal, 8(4), 1994, pp. 10000397-10000397
LOW-FREQUENCY MAGNETIC-FIELD EFFECTS ON HUMAN B-CELL GROWTH AND DIFFERENTIATION
Authors: CHAN O BERG M WANEBO H CHERLIN D POLK C MEHTA S
Citation: O. Chan et al., LOW-FREQUENCY MAGNETIC-FIELD EFFECTS ON HUMAN B-CELL GROWTH AND DIFFERENTIATION, The FASEB journal, 8(4), 1994, pp. 10000399-10000399
MECHANISM OF TAXOL MEDIATED NORMAL HUMAN T-CELL GROWTH-INHIBITION
Authors: BERG M BRENNAN M VICAN A KOUTTAB N WANEBO H MEHTA S
Citation: M. Berg et al., MECHANISM OF TAXOL MEDIATED NORMAL HUMAN T-CELL GROWTH-INHIBITION, The FASEB journal, 8(4), 1994, pp. 10000483-10000483
CONCURRENT CISPLATINUM AND RADIATION WITH OR WITHOUT SURGERY FOR ADVANCED HEAD AND NECK-CANCER
Authors: GLICKSMAN AS SLOTMAN G DOOLITTLE C CLARK J KONESS J COACHMAN N POSNER M DEROSA E WANEBO H
Citation: As. Glicksman et al., CONCURRENT CISPLATINUM AND RADIATION WITH OR WITHOUT SURGERY FOR ADVANCED HEAD AND NECK-CANCER, International journal of radiation oncology, biology, physics, 30(5), 1994, pp. 1043-1050
NUDE-MOUSE MODEL TO STUDY PASSIVE HUMORAL IMMUNOTHERAPY DIRECTED AGAINST B16-F10 MURINE MELANOMA
Authors: SHRAYER D BOGAARS H GERSTEN D HEARING V MAIZEL A WANEBO H
Citation: D. Shrayer et al., NUDE-MOUSE MODEL TO STUDY PASSIVE HUMORAL IMMUNOTHERAPY DIRECTED AGAINST B16-F10 MURINE MELANOMA, Journal of surgical oncology, 57(1), 1994, pp. 50-56
Risultati: 1-17 |